Clinical Trials and Research Studies
Phase 1
A Phase 1 First-in-Human Open Label Dose Escalation Study of MGD009 A Humanized B7-H3 x CD3 Dual-Affinity Re-Targeting (DART ) Protein in Patients with Unresectable or Metastatic B7-H3-Expressing Neoplasms and Neoplasms whose Vasculature Expresses
Phase 4
Surefire vs. Endhole for DEB-TACE: Quantifying Hepatic Artery Embolization to Improve Outcomes (A Comparison of Two Different Catheter Systems for DEB-TACE)
Phase 1/2
A PHASE 1/2 MULTICENTER OPEN-LABEL DOSE FINDING STUDY TO ASSESS THE SAFETY TOLERABILITY AND PRELIMINARY EFFICACY OF CC-122 IN COMBINATION WITH NIVOLUMAB IN SUBJECTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Phase 3
Treatment Of Children With All Stages Of Hepatoblastoma With Temsirolimus Added To High Risk Stratum Treatment